active
ACTIVE SINCE: 2011-2022

GSK – The University of Dundee collaborations on Neglected Tropical Diseases (NTDs) treatments

Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
Academia or research institute 1
Private Foundation or Development Organization 1
Objectives
  • Accelerate research into discovering and developing effective Neglected Tropical Diseases (NTD) treatments.

GSK and the Drug Discovery Unit (DDU) at the University of Dundee have a long-standing partnership to research Neglected Tropical Diseases (NTDs). In April 2017, the Wellcome Trust awarded the University of Dundee £7.9m for a joint five-project with GSK to boost efforts to find new drugs to treat some of the world’s most devastating parasitic diseases – visceral and cutaneous leishmaniasis, and Chagas’ disease.

Quote
"The collaboration with the University of Dundee and this funding from Wellcome are vital boosts towards the achievement of GSK’s goal of producing new preclinical candidates for leishmaniasis and/or Chagas’ disease."
 Dr Jose Fiandor
Director of GSK’s Kinetoplastids Discovery Performance Unit
Geographic Reach
  • Global Commitment
Disease Area
Target Population
  • Marginalized/indigenous people
  • People with low incomes
SGDs the partnership contributes to
SDG 3: Good Health and Well-being
  1. 3.3: Communicable Diseases & NTDs
  2. 3.8: Achieve universal health coverage
SDG 9: Industry Innovation and Infrastructure
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals 
Partner organizations
Academia or research institute

University of Dundee

Private Foundation or Development Organization

Wellcome Trust